Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Terminated 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 1

Conditions

Fatigue 1Anatomic Stage IV Breast Cancer AJCC v8 1

Interventions

Cisplatin 3202Cyclophosphamide 3195Carboplatin 2977Radiotherapy 2790Paclitaxel 2718Gemcitabine 2572pembrolizumab 2384Bevacizumab 2209Docetaxel 2199Fluorouracil 1851Capecitabine 1831Oxaliplatin 1742Dexamethasone 1605Nivolumab 1581Doxorubicin 1501Rituximab 1488Magnetic Resonance Spectroscopy 1387Etoposide 1346Irinotecan 1248Leucovorin 1226Drug Therapy 1205Cytarabine 1130Pemetrexed 1076fludarabine 1063Specimen Handling 1016Vincristine 964Cetuximab 945Trastuzumab 944Prednisone 941Lenalidomide 937

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
eicosapentaenoic acid ethanolamide × Clear all
NCT05198843 2025-10-03

Testing an Omega-3 Fatty Acid-Based Anti-Cancer Therapy for Patients With Triple-Negative Inflammatory Breast Cancer That Has Spread to Other Parts of the Body

National Cancer Institute (NCI)

Phase 1/2 Terminated
1 enrolled 5 charts
Breast

Anatomic Stage IV Breast Cancer AJCC v8

NCT02940223 2021-06-10

Ethyl Icosapentate and Physical Activity in Treating Fatigue in Patients With Advanced Cancer

M.D. Anderson Cancer Center

Phase 2 Terminated
2 enrolled 6 charts

Fatigue

Data powered by HemOnc (CC BY 4.0) Colophon âš¡